Related Experiment Video
Updated: Aug 5, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Is There a Risk of Clinical Consequences From Surgical Injury to the Superficial Middle Cerebral Vein? A Comparative
Michèle Yolande Moune1, Thomas Gaberel1,2
1Department of Neurosurgery, Caen University Hospital, Caen, France.
Background And Objectives:
Surgical management of unruptured middle cerebral artery (MCA) aneurysms may lead to the sacrifice of the middle cerebral vein, raising concerns about potential clinical consequences. Previous studies have reported increased postoperative edema with middle cerebral vein injury but without associated clinical symptoms. The aim of this study was to evaluate the clinical impact of middle cerebral vein injury in a homogeneous cohort of patients undergoing MCA aneurysm surgery.
Methods:
A retrospective cohort study was conducted, including patients treated for unruptured MCA aneurysms by microsurgery between January 2013 and May 2023. Inclusion required available pre- and postoperative arteriography and complete hospitalization records. The primary end point was the occurrence of postoperative clinical symptoms attributable to radiological parenchymal lesions suggestive of cerebral venous thrombosis.
Results:
Of 151 patients, 95 met inclusion criteria. Middle cerebral vein injury was identified in 30 of 95 cases (31.6%). Only 3 patients (3.2%) developed neurological symptoms potentially related to venous injury, all of which were resolved without unfavorable outcomes. No association was found between middle cerebral vein injury and clinical complications: 1 of 3 (33.3%) in the complication group had a vein injury vs 29 of 92 (31.5%) in the group without complications (P = .6). The risk of parenchymal lesion on computed tomography without clinical signs was 6 of 65 (9.2%) in patients without vein injury and 5 of 30 (16.6%) in those with vein injury (P = .3).
Conclusion:
Middle cerebral vein injury during unruptured MCA aneurysm surgery is frequent. The presence of such injury is not correlated with the occurrence of severe clinical events related to cerebral venous thrombosis. Preservation of the middle cerebral vein remains preferable, but sacrifice should not be considered an absolute contraindication if required by the surgical procedure.
Insights
Middle cerebral vein injury during middle cerebral artery aneurysm surgery is common but rarely causes severe symptoms. Sacrifice of this vein may be necessary and is not an absolute contraindication for surgery.
Area of Science:
- Neurosurgery
- Vascular Neurology
- Cerebrovascular Surgery
Background:
- Sacrificing the middle cerebral vein during middle cerebral artery aneurysm surgery raises concerns.
- Previous studies suggest increased edema but no clinical symptoms with middle cerebral vein injury.
Purpose of the Study:
- To evaluate the clinical impact of middle cerebral vein injury in patients undergoing middle cerebral artery aneurysm surgery.
Main Methods:
- Retrospective cohort study of patients treated for unruptured middle cerebral artery aneurysms.
- Inclusion criteria: microsurgery, pre/postoperative arteriography, complete hospitalization records.
- Primary endpoint: postoperative clinical symptoms linked to parenchymal lesions suggesting cerebral venous thrombosis.
Main Results:
- Middle cerebral vein injury occurred in 31.6% of 95 eligible patients.
- Only 3.2% developed transient neurological symptoms potentially related to venous injury.
- No significant association found between middle cerebral vein injury and clinical complications or radiological parenchymal lesions.
Conclusions:
- Middle cerebral vein injury is frequent in middle cerebral artery aneurysm surgery.
- Injury is not correlated with severe clinical events or cerebral venous thrombosis.
- Vein preservation is ideal, but sacrifice is not an absolute contraindication if surgically necessary.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
